Skip to main content
. 2016 Jan 1;7(1):50–59. doi: 10.7150/jca.13207

Figure 1.

Figure 1

Immunohistochemical examination of uMtCK expression in patient-derived normal and cancerous prostate tissues. Immunohistochemistry was used to analyze uMtCK in (A, B) benign gland tissues, (C, D) low Gleason grade prostate cancer tissues, and (E, F) high Gleason grade prostate cancer tissues. Scale bar = 40 µm.